Latest inventory for HTBX: $200B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Heat Biologics (HTBX) currently reports a inventory of $200B as of September 2025. Use the charts on this page to explore Heat Biologics's inventory history and peer comparisons.
Heat Biologics reported $200B in inventory as of September 2025. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current inventory of $200B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Heat Biologics, and consider following HTBX for alerts when major investors trade the stock.
Heat Biologics is classified in the Healthcare sector. On inventory, it currently shows $200B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTBX with unrelated industries.